skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis

Journal Article · · Journal of Medicinal Chemistry
 [1];  [2];  [3];  [3];  [4];  [4];  [1];  [5];  [1];  [6];  [4];  [6];  [6];  [2];  [6];  [7];  [4];  [3];  [6];  [1]
  1. Duquesne Univ., Pittsburgh, PA (United States)
  2. Barbara Ann Karmanos Cancer Inst., Detroit, MI (United States)
  3. Indiana Univ., Bloomington, IN (United States)
  4. Van Andel Research Inst., Grand Rapids, MI (United States)
  5. Wayne State Univ. School of Medicine, Detroit, MI (United States)
  6. Barbara Ann Karmanos Cancer Inst., Detroit, MI (United States); Wayne State Univ. School of Medicine, Detroit, MI (United States)
  7. Van Andel Research Inst., Grand Rapids, MI (United States); Chinese Academy of Sciences, Shanghai (China)

Targeted antifolates with heteroatom replacements of the carbon vicinal to the phenyl ring in 1 by N (4), O (8), or S (9), or with N-substituted formyl (5), acetyl (6), or trifluoroacetyl (7) moieties, were synthesized and tested for selective cellular uptake by folate receptor (FR) α and β or the proton-coupled folate transporter. Results show increased in vitro antiproliferative activity toward engineered Chinese hamster ovary cells expressing FRs by 4–9 over the CH2 analogue 1. Compounds 4–9 inhibited de novo purine biosynthesis and glycinamide ribonucleotide formyltransferase (GARFTase). X-ray crystal structures for 4 with FRα and GARFTase showed that the bound conformations of 4 required flexibility for attachment to both FRα and GARFTase. In mice bearing IGROV1 ovarian tumor xenografts, 4 was highly efficacious. Here, our results establish that heteroatom substitutions in the 3-atom bridge region of 6-substituted pyrrolo[2,3-d]pyrimidines related to 1 provide targeted antifolates that warrant further evaluation as anticancer agents.

Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Organization:
USDOE Office of Science (SC); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; National Inst. of Health; National Science Foundation (NSF); Ministry of Science and Technology
Grant/Contract Number:
AC02-06CH11357; 085P1000817; P30 CA022453; CA53535; CA125153; CA152316; CA166711; GM094472; DK071662; GM102545; GM104212; NSF91217311; 2012ZX09301001; 2012CB910403; 2013CB910600; XDB08020303; 2013ZX09507001
OSTI ID:
1330265
Journal Information:
Journal of Medicinal Chemistry, Vol. 59, Issue 17; ISSN 0022-2623
Publisher:
American Chemical Society (ACS)Copyright Statement
Country of Publication:
United States
Language:
ENGLISH
Citation Metrics:
Cited by: 27 works
Citation information provided by
Web of Science

References (68)

Human reduced folate carrier: translation of basic biology to cancer etiology and therapy journal March 2007
Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy journal April 2004
The molecular identity and characterization of a Proton-Coupled Folate Transporter—PCFT; biological ramifications and impact on the activity of pemetrexed—12 06 06 journal March 2007
The human proton-coupled folate transporter journal December 2012
Identification of an Intestinal Folate Transporter and the Molecular Basis for Hereditary Folate Malabsorption journal December 2006
Rodent intestinal folate transporters (SLC46A1): secondary structure, functional properties, and response to dietary folate restriction journal November 2007
Functional characterization of PCFT/HCP1 as the molecular entity of the carrier-mediated intestinal folate transport system in the rat model journal March 2008
Low-Dose Methotrexate Pharmacokinetics and Pharmacodynamics in the Therapy of Severe Psoriasis journal March 2005
Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance journal August 2012
The Antifolates journal June 2012
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis journal November 2007
Preclinical Pharmacology Studies and the Clinical Development of a Novel Multitargeted Antifolate, MTA (LY231514) book January 1999
Therapeutic Targeting of a Novel 6-Substituted Pyrrolo [2,3-d]pyrimidine Thienoyl Antifolate to Human Solid Tumors Based on Selective Uptake by the Proton-Coupled Folate Transporter journal September 2011
6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor α and the Proton-Coupled Folate Transporter in Human Tumors journal August 2015
Targeting Nonsquamous Nonsmall Cell Lung Cancer via the Proton-Coupled Folate Transporter with 6-Substituted Pyrrolo[2,3-d]Pyrimidine Thienoyl Antifolates journal February 2016
The folate receptor: What does it promise in tissue-targeted therapeutics? journal February 2007
Folate-Targeted Therapies for Cancer journal July 2010
Folate Receptor β Is Expressed by Tumor-Associated Macrophages and Constitutes a Marker for M2 Anti-inflammatory/Regulatory Macrophages journal December 2009
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis journal January 2006
Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors journal May 2015
Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications journal January 2015
PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer journal December 2013
BGC 945, a Novel Tumor-Selective Thymidylate Synthase Inhibitor Targeted to α-Folate Receptor–Overexpressing Tumors journal December 2005
Synthesis and Discovery of High Affinity Folate Receptor-Specific Glycinamide Ribonucleotide Formyltransferase Inhibitors with Antitumor Activity journal August 2008
Synthesis and Antitumor Activity of a Novel Series of 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Antifolate Inhibitors of Purine Biosynthesis with Selectivity for High Affinity Folate Receptors and the Proton-Coupled Folate Transporter over the Reduced Folate Carrier for Cellular Entry journal January 2010
Synthesis, Biological, and Antitumor Activity of a Highly Potent 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Antifolate Inhibitor with Proton-Coupled Folate Transporter and Folate Receptor Selectivity over the Reduced Folate Carrier That Inhibits β-Glycinamide Ribonucleotide Formyltransferase journal September 2011
Synthesis and Biological Activity of 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Inhibitors of de Novo Purine Biosynthesis with Selectivity for Cellular Uptake by High Affinity Folate Receptors and the Proton-Coupled Folate Transporter over the Reduced Folate Carrier journal February 2012
Discovery of 5-Substituted Pyrrolo[2,3- d ]pyrimidine Antifolates as Dual-Acting Inhibitors of Glycinamide Ribonucleotide Formyltransferase and 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase in De Novo Purine Nucleotide Biosynthesis: Implications of Inhibiting 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase to AMPK Activation and Antitumor Activity journal December 2013
Tumor-Targeting with Novel Non-Benzoyl 6-Substituted Straight Chain Pyrrolo[2,3- d ]pyrimidine Antifolates via Cellular Uptake by Folate Receptor α and Inhibition of de Novo Purine Nucleotide Biosynthesis journal October 2013
Structure–Activity Profiles of Novel 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Antifolates with Modified Amino Acids for Cellular Uptake by Folate Receptors α and β and the Proton-Coupled Folate Transporter journal September 2014
Preclinical and Clinical Evaluation of the Glycinamide Ribonucleotide Formyltransferase Inhibitors Lometrexol and LY309887 book January 1999
AG2034: a novel inhibitor of glycinamide ribonucleotide formyltransferase journal September 1996
Phase I dose-escalation and pharmacokinetic study of a novel folate analogue AG2034 journal February 2001
Phase I and pharmacokinetic study of LY309887: a specific inhibitor of purine biosynthesis journal June 2001
Phase I Study of (6R)-5, 10-Dideazatetrahydrofolate: a Folate Antimetabolite Inhibitory to De Novo Purine Synthesis journal July 1993
Rational Design, Synthesis, Evaluation, and Crystal Structure of a Potent Inhibitor of Human GAR Tfase:  10-(Trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic Acid, journal May 2003
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design journal April 2011
The Apo and Ternary Complex Structures of a Chemotherapeutic Target:  Human Glycinamide Ribonucleotide Transformylase, journal June 2005
Structural basis for molecular recognition of folic acid by folate receptors journal July 2013
Isolation of Human cDNAs That Restore Methotrexate Sensitivity and Reduced Folate Carrier Activity in Methotrexate Transport-defective Chinese Hamster Ovary Cells journal July 1995
Synthesis and Biological Activity of a Novel Series of 6-Substituted Thieno[2,3-d]pyrimidine Antifolate Inhibitors of Purine Biosynthesis with Selectivity for High Affinity Folate Receptors over the Reduced Folate Carrier and Proton-Coupled Folate Transporter for Cellular Entry journal April 2009
Isolation and partial characterization of three methotrexate-resistant phenotypes from Chinese hamster ovary cells journal May 1976
Targeting the Proton-Coupled Folate Transporter for Selective Delivery of 6-Substituted Pyrrolo[2,3-d]Pyrimidine Antifolate Inhibitors of De Novo Purine Biosynthesis in the Chemotherapy of Solid Tumors journal July 2010
Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition journal August 2013
Novel 5-Substituted Pyrrolo[2,3- d ]pyrimidines as Dual Inhibitors of Glycinamide Ribonucleotide Formyltransferase and 5-Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase and as Potential Antitumor Agents journal February 2015
Molecular basis of antifolate resistance journal February 2007
Presenting your structures: the CCP 4 mg molecular-graphics software journal March 2011
Docking Validation Resources: Protein Family and Ligand Flexibility Experiments journal October 2010
DOCK 6: Impact of new features and current docking performance journal April 2015
ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB journal July 2015
UCSF Chimera?A visualization system for exploratory research and analysis journal January 2004
Functional Loss of the Reduced Folate Carrier Enhances the Antitumor Activities of Novel Antifolates with Selective Uptake by the Proton-Coupled Folate Transporter journal June 2012
Protein Measurement with the Folin Phenol Reagent journal November 1951
Conversion of Uracil Deoxyriboside to Thymidine of Deoxyribonucleic acid journal June 1956
The Human Glycinamide Ribonucleotide Transformylase Domain: Purification, Characterization, and Kinetic Mechanism journal May 1997
Discovery of cryptophycin-1 and BCN-183577: Examples of strategies and problems in the detection of antitumor activity in mice journal September 1997
The Yeast HtrA Orthologue Ynm3 Is a Protease with Chaperone Activity that Aids Survival Under Heat Stress journal January 2009
Transplantable Syngeneic Rodent Tumors: Solid Tumors in Mice book November 2010
Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice journal June 1997
Long-Term Folate Deficiency Alters Folate Content and Distribution Differentially in Rat Tissues journal April 1992
Recent developments in the PHENIX software for automated crystallographic structure determination journal November 2003
PHENIX : building new software for automated crystallographic structure determination journal October 2002
Coot model-building tools for molecular graphics journal November 2004
Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard journal December 2007
XDS journal January 2010
The CCP4 suite programs for protein crystallography journal September 1994
Phaser crystallographic software journal July 2007
Refinement of Macromolecular Structures by the Maximum-Likelihood Method journal May 1997

Similar Records

A structural snapshot of the rhodopsin-arrestin complex
Journal Article · Sun Nov 01 00:00:00 EDT 2015 · Federation of European Biochemical Societies (FEBS) Journal · OSTI ID:1330265

Structural basis for recognition of diverse transcriptional repressors by the TOPLESS family of corepressors
Journal Article · Fri Jul 03 00:00:00 EDT 2015 · Science Advances · OSTI ID:1330265

Structural basis for corepressor assembly by the orphan nuclear receptor TLX
Journal Article · Sun Feb 15 00:00:00 EST 2015 · Genes & Development · OSTI ID:1330265